Remove Drug Research Remove Pharmaceuticals Remove Trials
article thumbnail

Product Highlight: DrugBank on Snowflake Marketplace

DrugBank

At DrugBank, we’re dedicated to empowering pharmaceutical researchers with data that drives impactful results. This lets you focus on what matters most: driving meaningful results in drug research and development. In fact, poor data quality is estimated to cost U.S.

article thumbnail

Pediatric Development Plans: Key Considerations

Cytel

Historically, many drugs have been prescribed to children even though this patient population have largely been excluded from clinical trials. There is an obvious logic. If medicines are to be used in children, they need to be studied in pediatric populations to ensure they are safe and effective.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research

Vial

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research Randomized clinical trials are the gold-standard of evidence-based medicine, representing the culmination of the long, arduous drug development pipeline. What is a Pre-Clinical CRO? The global preclinical CRO market was estimated to be valued at US$5.7

article thumbnail

Deliberate Dysentery

Codon

Human challenge trials were an indispensable part of the development of the malaria vaccine, R21/Matrix-M, endorsed by the World Health Organization last October. But for all of their benefits, human challenge trials have their drawbacks. Jake himself has participated in both Zika and Shigella challenge trials.

Vaccine 108
article thumbnail

An Evolving Regulatory Environment for Rare and Orphan Diseases

Advarra

Orphan drugs have historically faced a number of barriers, such as limited research and development (R&D) investment due to an expected lack of profitability as well as challenges in clinical trial design and recruitment. Before 1983, only 38 orphan drugs had received U.S. Food and Drug Administration (FDA) approval.

Disease 52
article thumbnail

AI in gene delivery vector discovery and design

Drug Target Review

Consequently, an increasing number of academic researchers and companies are entering this field. Much like models such as ChatGPT that showcase AI’s vast capabilities in natural language processing and knowledge understanding, AI large language models (LLM) also hold immense potential in life sciences and pharmaceuticals.

article thumbnail

Article EMA Thank You What we expect European regulators to do in August and September 2024

Agency IQ

While the work on the pharma package will likely take quite some time, another deadline is coming up fast: the full transition of all clinical trials from the Clinical Trials Directive to the Clinical Trials Regulation.